DOSE OF REALITY: DRUG MAKERS INCREASINGLY UTILIZING DEVICE PATENTS TO EXTEND EXCLUSIVITY ON BLOCKBUSTER DRUGS
Jan 9, 2026
New Research Shows Drugmakers Increasingly Rely on Patents Disconnected from… Read More
© 2026 CSRXP- All Rights Reserved
Dose of Reality
DOSE OF REALITY: NEW REPORT PROJECTS MORE THAN 50 PERCENT DROP IN OUT-OF-POCKET COSTS FOR TOP MEDICARE DRUGS IN 2026
Jan 6, 2026
AARP Analysis Highlights Substantial Cost Savings for Nearly Nine Million… Read More
Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part IV: Big Pharma’s Debunked Innovation Rhetoric
Dec 31, 2025
Big Pharma Undercut Its Own False Claims About Innovation in 2025 With each… Read More
Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part III: Big Pharma’s Anti-Competitive Tactics That Keep Prices High
Dec 30, 2025
Exploring Big Pharma’s Egregious Abuse of the Patent System Designed to… Read More
Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part II: Big Pharma’s DTC Advertising
Dec 29, 2025
Big Pharma’s Aggressive Marketing Directly Targeting Consumers to Boost… Read More
Dose of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part I: Big Pharma’s Egregious Pricing Practices
Dec 29, 2025
Take a Look Back on Big Pharma’s Year of Price Hikes and Increasingly… Read More
DOSE OF REALITY: STUDY FURTHER HIGHLIGHTS THE COST OF BIG PHARMA’S BLOCKBUSTER BAILOUT
Nov 20, 2025
Analysis Finds Excluding Brand Name Drugs Approved to Treat Rare Diseases from… Read More
DOSE OF REALITY: JAMA NETWORK ANALYSIS SHINES LIGHT ON HOW BIG PHARMA PUSHES SALES OF HIGH-PRICED BLOCKBUSTERS BY TARGETING CONSUMERS ON SOCIAL MEDIA
Nov 19, 2025
Brand Name Drug Companies Sidestep Guardrails Meant to Protect American… Read More
DOSE OF REALITY: NEW ICER REPORT FINDS BIG PHARMA CONTINUES SETTING INCREASINGLY OUT-OF-CONTROL LAUNCH PRICES UNJUSTIFIED BY CLINICAL VALUE
Oct 27, 2025
Launch Prices for 23 New Treatments Exceeding Estimates for a Fair Price Cost… Read More
DOSE OF REALITY: MERCK SURPASSES MILESTONE IN PRODUCT-HOPPING STRATEGY TO BLOCK COMPETITION, KEEP PRICES HIGH ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Oct 22, 2025
DOSE OF REALITY: MERCK SURPASSES MILESTONE IN PRODUCT-HOPPING STRATEGY TO… Read More
DOSE OF REALITY: CONGRESS MUST REPEAL BIG PHARMA’S BLOCKBUSTER BAILOUT THAT WILL COST SENIORS AND TAXPAYERS BILLIONS OF DOLLARS IN PREVIOUSLY UNDERESTIMATED COSTS
Oct 20, 2025
ORPHAN Cures Act Will Enable Big Pharma to Keep Drug Prices High on Top Money… Read More
DOSE OF REALITY: BIG PHARMA’S QUICK DELISTING OF MORE THAN 40 SHAM PATENTS HIGHLIGHTS SCALE OF PATENT THICKETS ON TOP MONEY-MAKERS
Sep 18, 2025
Analysis Finds Brand Name Drug Companies Declined to Even Attempt a Defense of… Read More